{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-061616","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.452787+00:00","generated_at":"2026-06-01T16:46:52.771533+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioAtla settles shareholder derivative suit, pays $350K in fees after bylaw reforms","bullets":["Company paid $350,000 in attorneys' fees to settle claims over bylaw amendments imposing disclosure requirements on dissident director nominations.","BioAtla amended bylaws on April 22, 2024, to address challenged provisions; company denies all wrongdoing.","Delaware Court of Chancery closed the action on May 15, 2024, subject to filing notice to putative class.","Plaintiff alleged directors breached fiduciary duties by adopting bylaw amendments on January 5, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-061616","json":"https://secwatch.observer/filing/0000950170-24-061616.json","markdown":"https://secwatch.observer/filing/0000950170-24-061616.md","text":"https://secwatch.observer/filing/0000950170-24-061616.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000095017024061616/0000950170-24-061616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000095017024061616/bcab-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T16:46:52.771533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}